KCAS Bioanalytical Services
Dawn R. Dufield is the Senior Director of Biopharmaceuticals (LC-MS/MS) Services at KCAS. Previously she had been with Pfizer and legacy companies for over 20 years working in the quantitative LC-MS/MS field. She was one of the early pioneers of using immunoaffinity combined with LC-MS/MS to offer additional selectivity which is now commonly referred to as Hybrid LCMS. She currently is a member of the AAPS Mass Spec Protein Bioanalysis Committee (MSPBC) and an active member of the American Society for Mass Spectrometry (ASMS). She has numerous publications and presentations in her field and recently contributed to a white paper on recommendations for validation of LCMS based bioanalytical methods for protein biotherapeutics.
Dawn received her Ph.D. in BioAnalytical Chemistry (Honors) from the University of Kansas in Lawrence, K. She earned her bachelors degree in Chemistry, (Computer minor) from Southwest Missouri State University in Springfield, MO.
This person is not in the org chart
This person is not in any offices
KCAS Bioanalytical Services
1 followers
KCAS Bioanalytical and Biomarker Services, an Integris BioServices, LLC Company is a rapidly growing company that provides comprehensive GLP / GCP compliant development services from early discovery support through product registration and beyond. KCAS provides a truly differentiated approach as one of only a select few CROs offering both large and small molecule development with extensive capabilities and expertise to its clients who are looking for both scientific expertise and excellent customer service.